The impact of benign gene expression classifier test results on the endocrinologist-patient decision to operate on patients with thyroid nodules with indeterminate fine-needle aspiration cytopathology

Thyroid

Volumn 22, Issue 10, 2012, Pages 996-1001

  Duick, Daniel S ^a   Klopper, Joshua P ^b   Diggans, James C ^c   Friedman, Lyssa ^c   Kennedy, Giulia C ^c   Lanman, Richard B ^c   McIver, Bryan ^d  

^a Endocrinology Associates   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c Veracyte Inc   (United States)

^d MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLASSIFIER; CLINICAL PRACTICE; CONTROLLED STUDY; CYTOLOGY; CYTOPATHOLOGY; DOCTOR PATIENT RELATION; ENDOCRINOLOGIST; FEMALE; GENE EXPRESSION; GENE EXPRESSION CLASSIFER; HUMAN; MAJOR CLINICAL STUDY; MALE; NEEDLE BIOPSY; PATIENT DECISION MAKING; PHYSICIAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; THYROID NODULE; THYROIDECTOMY;

BIOPSY, FINE-NEEDLE; COHORT STUDIES; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; PATIENT PARTICIPATION; RETROSPECTIVE STUDIES; THYROID NODULE;

EID: 84866999215     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2012.0180     Document Type: Article

References (25)

1. Mazzaferri EL 1993 Management of a solitary thyroid nodule. N Engl J Med 328:553-559. (Pubitemid 23053833)
2. American Cancer Society 2012 Cancer Facts & Figures. Atlanta: American Cancer Society. Available at www.cancer.org/acs/groups/content/ @epidemiologysurveilance/documents/document/acspc-031941.pdf (accessed April 17, 2012).
3. Caruso DR, Mazzaferri EL 1991 Fine needle aspiration biopsy in the management of thyroid nodules. Endocrinologist 1:194-202.
4. Yassa L, Cibas ES, Benson CB, Frates MC, Doubilet PM, Gawande AA, Moore FD Jr., Kim BW, Nosé V, Marqusee E, Larsen PR, Alexander EK 2007 Long-term assessment of a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer 111:508-516. (Pubitemid 350304903)
5. Gharib H, Papini E, Paschke R, Duick DS, Valcavi R, He-gedüs L, Vitti P 2010 American Association of Clinical En-docrinologists, AssociazioneMedicieEndocrinologi, and European Thyroid Association medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. J En-docrinol Invest 33:51-56.
6. Cooper DS, Doherty GM, Haugen BR, Hauger BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214.
7. Gharib H, Goellner JR 1993 Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med 118:282-289. (Pubitemid 23046388)
8. Wang CC, Friedman L, Kennedy GC, Wang H, Kebebew E, Steward DL, Zeiger MA, Westra WH, Wang Y, Khanafshar E, Fellegara G, Rosai J, Livolsi V, Lanman RB 2011 A large multicenter correlation study of thyroid nodule cytopathol-ogy and histopathology. Thyroid 21:243-251.
9. Grant CS, Hay ID, Gough IR, McCarthy PM, Goellner JR 1989 Long-term follow-up of patients with benign thyroid fine-needle aspiration cytologic diagnoses. Surgery 106:980-985.
10. Cibas ES, Syed AZ 2009 NCI Thyroid FNA state of the science conference. The Bethesda System for reporting thyroid cytopathology. Am J Clin Pathol 132:658-665.
11. Gharib H, Papini E, Paschke R 2008 Thyroid nodules: a review of current guidelines, practices, and prospects. Eur J Endocrinol 159:493-505.
12. Bryson PC, Shores CG, Hart C, Thorne L, Patel MR, Richey L, Farag A, Zanation AM 2008 Immunohistochemical distinction of follicular thyroid adenomas and follicular carcinomas. Arch Otolaryngol Head Neck Surg 134:581-586. (Pubitemid 351871015)
13. Chudova D, Wilde JI, Wang ET, Wang H, Rabbee N, Egidio CM, Reynolds J, Tom E, Pagan M, Rigl CT, Friedman L, Wang CC, Lanman RB, Zeiger M, Kebebew E, Rosai J, Fellegara G, LiVolsi VA, Kennedy GC 2010 Molecular classification of thyroid nodules using high-dimensionality ge-nomic data. J Clin Endocrinol Metab 95:5296-5304.
14. Haugen BR, Baloch ZW, Chudova D, Cibas E, Friedman L, Kennedy GC, Kloos RT, Lanman RB, LiVolsi VA, Mandel SJ, Steward D, Raab S, Rosai J, Wang CC, Wang ET, Wilde JI, Zeiger M, Alexander EK 2010 Development of a novel molecular classifier to accurately identify benign thyroid nodules in patients with indeterminate FNA cytology. Program of the 14th International Thyroid Congress, Paris, France, 2010, p 64. Abstract LB-06.
15. Li H, Robinson KA, Anton B, Saldanha IJ, Ladenson PW 2011 Cost-effectiveness of a novel molecular test for cyto-logically indeterminate thyroid nodules. J Clin Endocrinol Metab 96:E1719-E1726.
16. Banks ND, Kowalsk J, Tsai H-L, Somervell H, Tufano R, Dackiw APB, Marohn MR, Clark DP, Umbricht CB, Zeiger MA 2008 A diagnostic predictor model for indeterminate or suspicious thyroid FNA samples. Thyroid 18:933-941.
17. Hegedüs L 2004 Clinical practice. The thyroid nodule. N Engl J Med 351:1764-1771.
18. Mitchell I, Livingston EH, Chang AY, Holt S, Snyder WH 3rd, Lingvay I, Nwariaku FE 2007 Trends in thyroid cancer demographics and surgical therapy in the United States. Surgery 142:823-828. (Pubitemid 350184103)
19. Fusco A, Gennaro C, Hui P, Garcia-Rostan G, Golden L, Kinder BK, Dillon DA, Giuliano A, Cirafici AM, Santoro M, Rosai J, Tallini G 2002 Assessment of RET/PTC oncogene activation and clonality in thyroid nodules with incomplete morphological evidence of papillary carcinoma. Am J Path 160:2157-2167. (Pubitemid 34663407)
20. Porterfield JR Jr, Grant CS, Dean DS, Thompson GB, Farley DR, Richards ML, Reading CC, Charboneau JW, Vollrath BK, Sebo TJ 2008 Reliability of benign fine needle aspiration cytology of large thyroid nodules. Surgery 144:963-968.
21. Monroe R, Zalles C, Traweek T, O'Reilly K, Romanowsky J, Brunt K, Kennedy GC, Lanman RB 2011 Clinical practice impact of a novel mRNA-based gene expression classifier in thyroid nodules with indeterminate fine needle aspiration cytopathology. Thyroid 21:A-101 (Poster 244; abstract).
22. Duick DS, Klopper JP, Diggans J, Friedman L, Kennedy GC, Lanman RB, Romanowsky J, McIver BM 2012 The impact of benign gene expression classifier test results on the physician decision-to-operate in patient with thyroid nodules with indeterminate FNA cytology. Abstract presented at the American Association of Clinical Endocrinologists Annual Meeting Philadelphia, May (abstract).
23. Tuggle CT, Park LS, Roman S, Udelsman R, Sosa JA 2010 Rehospitalization among elderly patients with thyroid cancer after thyroidectomy are prevalent and costly. Ann Surg Oncol 17:2816-2823.
24. Teutsch SM, Bradley LA, Palomaki GE, Haddow JE, Piper M, Calonge N, Dotson WD, Douglas MP, and Berg AO 2009 The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP working group. Genet Med 11:3-14.
25. Alexander EK, Kennedy GC, Baloch ZW, Cibas ES, Chudova D, Diggans J, Friedman L, Kloos RT, Livolsi VA, Mandel SJ, Raab SS, Rosai J, Steward DL, Walsh PS, Wilde JI, Zeiger MA, Lanman RB, Haugen BR 2012 Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med [Epub ahead of print]; DOI: 10.1056/NEJMoa1203208.